Skip to main content

How Doctors Choose Parkinson's Medications

September 15, 2016

In this webinar, our panelists discuss how doctors and patients work together to choose what medications to start, adjust or discontinue. We also answer common medication questions, including "When should one start levodopa?" and "What does prescribing off label mean?"

Webinar Details


Thursday, September 15, 2016


1 hr


12:00 pm ET

  • MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: September 15, 2016
    Date CME Credit No Longer Available: September 15, 2018

    Learning Objectives

    At the conclusion of this course, participants should be able to:

    1. Describe how medications are selected and adjusted to manage Parkinson's motor and non-motor symptoms.
    2. Discuss the pros and cons of levodopa therapy, including early vs. later initiation.
    3. Recognize best practices in starting and discontinuing Parkinson's medications.
    4. Define "off label" prescribing.
    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Dave Iverson
    Nothing to disclose

    Thomas L. Davis, MD
    Professor of Neurology
    Director, Division of Movement Disorders

    Vanderbilt University Medical Center
    Disclosures: AbbVie Pharmaceuticals

    Rachel Dolhun, MD
    Vice President, Medical Communications
    The Michael J. Fox Foundation

    No disclosures

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.